Dr. Peter R. Kowey, MD
Cardiology (Cardiovascular Disease Physician)
100 E Lancaster Ave, J.d Lankenau Pavilion, Mezzanine
Wynnewood, PA 19096
- Medicare participating
At a glance
- Medical school
- Perelman School of Med at the University of Pennsylvania (1975)
- Years since graduation
- 51
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 2,970
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1975Medical school: Perelman School of Med at the University of Pennsylvania
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
PA license MD017937E -
Clinical Cardiac Electrophysiology Physician
PA license MD017937E
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Thomas Jefferson University Hospital Philadelphia, PA
- Main Line Hospital Lankenau Wynnewood, PA
- Paoli Hospital Paoli, PA
- Bryn Mawr Hospital Bryn Mawr, PA
- Riddle Memorial Hospital Media, PA
Medical groups
- Main Line Healthcare (1,184 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 2,970
- Services billed
- 5,021
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 4,528 | 2,849 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 208 | 172 |
| Established patient office or other outpatient visit, 20-29 minutes | 197 | 168 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Wynnewood, PA | 16 |
| Xarelto (rivaroxaban) Other prescribers in Wynnewood, PA | 15 |
| Metoprolol Succinate Other prescribers in Wynnewood, PA | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 62 payments worth $224,461 in total to this clinician.
| Sanofi US Services Inc. | $50,108 |
|---|---|
| E.r. Squibb & Sons, L.l.c. | $46,213 |
| GlaxoSmithKline, LLC. | $35,500 |
| Janssen Research & Development, LLC | $31,610 |
| Syndax Pharmaceuticals, Inc. | $14,625 |
| Bridgebio Pharma, Inc. | $9,750 |
| AstraZeneca UK Limited | $9,550 |
| UCB SA | $6,000 |
| Consulting Fee | $224,461 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| E.r. Squibb & Sons, L.l.c. Dec 12, 2025 | Consulting Fee | $22,813 |
| E.r. Squibb & Sons, L.l.c. Sep 22, 2025 | Consulting Fee | $15,000 |
| Sanofi US Services Inc. Feb 26, 2025 | Consulting Fee DUPIXENT · Immunology | $10,248 |
| Sanofi US Services Inc. Sep 6, 2025 | Consulting Fee DUPIXENT · Immunology | $9,821 |
| Sanofi US Services Inc. Feb 26, 2025 | Consulting Fee DUPIXENT · Immunology | $9,821 |
| Sanofi US Services Inc. May 19, 2025 | Consulting Fee DUPIXENT · Immunology | $8,540 |
| GlaxoSmithKline, LLC. Oct 30, 2025 | Consulting Fee | $7,600 |
| Sanofi US Services Inc. May 16, 2025 | Consulting Fee MULTAQ · Cardiology/Vascular Diseases | $7,408 |
| GlaxoSmithKline, LLC. Jun 6, 2025 | Consulting Fee | $6,800 |
| Syndax Pharmaceuticals, Inc. Mar 28, 2025 | Consulting Fee REVUFORJ · HEMATOLOGY-ONCOLOGY | $6,500 |
All 62 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. Dec 19, 2025 | Consulting Fee | $4,200 |
| Bridgebio Pharma, Inc. Dec 16, 2025 | Consulting Fee Attruby · Cardiomyopathy | $3,250 |
| GlaxoSmithKline, LLC. Dec 15, 2025 | Consulting Fee | $6,000 |
| E.r. Squibb & Sons, L.l.c. Dec 12, 2025 | Consulting Fee | $22,813 |
| Alnylam Pharmaceuticals Inc. Nov 26, 2025 | Consulting Fee | $1,410 |
| AstraZeneca UK Limited Nov 25, 2025 | Consulting Fee | $675 |
| Syndax Pharmaceuticals, Inc. Nov 7, 2025 | Consulting Fee REVUFORJ · HEMATOLOGY-ONCOLOGY | $4,550 |
| Bridgebio Pharma, Inc. Nov 4, 2025 | Consulting Fee Attruby · Cardiomyopathy | $1,500 |
| Janssen Research & Development, LLC Nov 3, 2025 | Consulting Fee | $3,250 |
| GlaxoSmithKline, LLC. Oct 30, 2025 | Consulting Fee | $7,600 |
| Janssen Research & Development, LLC Oct 27, 2025 | Consulting Fee | $5,580 |
| E.r. Squibb & Sons, L.l.c. Oct 27, 2025 | Consulting Fee Sotyktu · Immunology | $4,500 |
| AstraZeneca UK Limited Oct 22, 2025 | Consulting Fee SAPHNELO · Inflammation and Autoimmunity | $1,500 |
| Syndax Pharmaceuticals, Inc. Oct 10, 2025 | Consulting Fee REVUFORJ · HEMATOLOGY-ONCOLOGY | $3,575 |
| Janssen Research & Development, LLC Oct 10, 2025 | Consulting Fee | $1,200 |
| AstraZeneca UK Limited Oct 9, 2025 | Consulting Fee SAPHNELO · Inflammation and Autoimmunity | $600 |
| Novo Nordisk As Oct 6, 2025 | Consulting Fee | $3,140 |
| GlaxoSmithKline, LLC. Oct 3, 2025 | Consulting Fee | $1,200 |
| E.r. Squibb & Sons, L.l.c. Sep 22, 2025 | Consulting Fee | $15,000 |
| Takeda Pharmaceuticals U.S.A., Inc. Sep 16, 2025 | Consulting Fee | $600 |
| UCB SA Sep 12, 2025 | Consulting Fee Bimzelx · Immunology | $900 |
| Sanofi US Services Inc. Sep 6, 2025 | Consulting Fee DUPIXENT · Immunology | $9,821 |
| GlaxoSmithKline, LLC. Aug 26, 2025 | Consulting Fee | $5,200 |
| Bridgebio Pharma, Inc. Aug 5, 2025 | Consulting Fee Attruby · Cardiomyopathy | $5,000 |
| Janssen Research & Development, LLC Jul 14, 2025 | Consulting Fee | $600 |
| Janssen Research & Development, LLC Jun 10, 2025 | Consulting Fee | $6,200 |
| GlaxoSmithKline, LLC. Jun 6, 2025 | Consulting Fee | $6,800 |
| AstraZeneca UK Limited Jun 5, 2025 | Consulting Fee SAPHNELO · Inflammation and Autoimmunity | $600 |
| UCB SA May 30, 2025 | Consulting Fee Bimzelx · Immunology | $1,800 |
| AstraZeneca UK Limited May 23, 2025 | Consulting Fee | $1,800 |
| E.r. Squibb & Sons, L.l.c. May 22, 2025 | Consulting Fee Sotyktu · Immunology | $2,400 |
| AbbVie Inc. May 21, 2025 | Consulting Fee SKYRIZI · IMMUNOLOGY | $650 |
| Sanofi US Services Inc. May 19, 2025 | Consulting Fee DUPIXENT · Immunology | $8,540 |
| Sanofi US Services Inc. May 16, 2025 | Consulting Fee MULTAQ · Cardiology/Vascular Diseases | $7,408 |
| Janssen Research & Development, LLC May 12, 2025 | Consulting Fee | $4,030 |
| Janssen Research & Development, LLC May 9, 2025 | Consulting Fee | $2,480 |
| GlaxoSmithKline, LLC. May 7, 2025 | Consulting Fee | $4,400 |
| AstraZeneca UK Limited May 2, 2025 | Consulting Fee | $1,138 |
| AstraZeneca UK Limited Apr 28, 2025 | Consulting Fee | $1,138 |
| Takeda Pharmaceuticals U.S.A., Inc. Apr 23, 2025 | Consulting Fee | $600 |
| Janssen Research & Development, LLC Apr 21, 2025 | Consulting Fee | $1,200 |
| AstraZeneca UK Limited Apr 16, 2025 | Consulting Fee SAPHNELO · Inflammation and Autoimmunity | $900 |
| Alnylam Pharmaceuticals Inc. Apr 10, 2025 | Consulting Fee | $705 |
| AbbVie Inc. Apr 7, 2025 | Consulting Fee SKYRIZI · IMMUNOLOGY | $2,275 |
| Syndax Pharmaceuticals, Inc. Mar 28, 2025 | Consulting Fee REVUFORJ · HEMATOLOGY-ONCOLOGY | $6,500 |
| Bausch Health US, LLC Mar 26, 2025 | Consulting Fee | $1,350 |
| UCB SA Mar 14, 2025 | Consulting Fee Bimzelx · Immunology | $1,200 |
| AstraZeneca UK Limited Mar 12, 2025 | Consulting Fee SAPHNELO · Inflammation and Autoimmunity | $1,200 |
| Sanofi US Services Inc. Feb 26, 2025 | Consulting Fee DUPIXENT · Immunology | $10,248 |
| Sanofi US Services Inc. Feb 26, 2025 | Consulting Fee DUPIXENT · Immunology | $9,821 |
| Sanofi US Services Inc. Feb 26, 2025 | Consulting Fee DUPIXENT · Immunology | $4,270 |
| GlaxoSmithKline, LLC. Feb 25, 2025 | Consulting Fee | $1,500 |
| Janssen Research & Development, LLC Feb 19, 2025 | Consulting Fee | $5,270 |
| GlaxoSmithKline, LLC. Feb 13, 2025 | Consulting Fee | $2,800 |
| AbbVie Inc. Feb 6, 2025 | Consulting Fee SKYRIZI · IMMUNOLOGY | $1,625 |
| Janssen Research & Development, LLC Feb 3, 2025 | Consulting Fee | $1,800 |
| E.r. Squibb & Sons, L.l.c. Jan 31, 2025 | Consulting Fee Sotyktu · Immunology | $1,500 |
| UCB SA Jan 10, 2025 | Consulting Fee Bimzelx · Immunology | $2,100 |
| ModernaTX, Inc. Jan 8, 2025 | Consulting Fee | $2,600 |
| ModernaTX, Inc. Jan 8, 2025 | Consulting Fee | $1,300 |
| ModernaTX, Inc. Jan 8, 2025 | Consulting Fee | $325 |
| ModernaTX, Inc. Jan 8, 2025 | Consulting Fee | $325 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.